相关实验视频

Updated: Jun 7, 2025

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

通过集群定期间隔的短Palindromic重复 (CRISPR) -Cas技术彻底改变了结核病管理:全面的文献审查

Achal Shetty¹, Hamida Kwas², Hayfa Rajhi³

¹Community Medicine, Father Muller Medical College, Mangalore, IND.

|November 18, 2024

概括

集群定期间隔的短平行体重复 (CRISPR) -Cas系统为结核病 (TB) 诊断和治疗提供了一种革命性的方法. 这种先进的技术提高了结核病管理的早期检测和个性化治疗.

科学领域:

分子生物学分子生物学
遗传学是一个遗传学.
传染性疾病传染性疾病

背景情况:

目前的结核病 (TB) 诊断面临的局限性包括耗时的方法和依赖聚合酶链反应 (PCR).
集群定期间隔的短平行体重复 (CRISPR) -Cas系统呈现了一种具有结核病管理潜力的新型遗传向技术.

研究的目的:

探索CRISPR-Cas系统在改善结核病诊断和治疗中的应用.
突出CRISPR-Cas技术在传统结核病诊断方法上的优势.

主要方法:

利用CRISPR-Cas12和Cas13通过跨裂变活性和光信号来快速检测结核病.
采用异热放大技术,如重组酶聚合酶放大 (RPA) 和循环介导异热放大 (LAMP),以提高灵敏度.
利用CRISPR-Cas基因组编辑能力研究结核病耐药性机制和毒性因素.

主要成果:

克里斯普尔-卡斯系统在检测Mycobacterium tuberculosis方面表现出高的特异性和灵敏性,即使在细菌负载较低的样本中也是如此.
与CRISPR相结合的异热放大方法减少了与传统PCR相比的设备需求.
基因组编辑有助于研究与结核病毒性和抗生素耐药性相关的基因.

结论:

克里斯普尔-卡斯技术为快速,准确的结核病诊断和潜在的治疗策略提供了一个有前途的途径.
多重检测的进步和临床实用性是广泛采用的关键.
将CRISPR集成到结核病管理中可以导致更早的检测,明智的治疗决策和新疗法的开发.

关键词:

克里斯普-卡斯系统 (集群定期间隔的短时间的平行体重复) -克里斯普关联系统.基因编辑Crispr/Cas9基因编辑基因编辑基因编辑多种耐药细菌的多种耐药细菌.结核病是一种肺结核病.

更多相关视频

Application of CRISPR Interference CRISPRi for Gene Silencing in Pathogenic Species of Leptospira

Application of CRISPR Interference CRISPRi for Gene Silencing in Pathogenic Species of Leptospira

Published on: August 14, 2021

Production of Human CRISPR-Engineered CAR-T Cells

Production of Human CRISPR-Engineered CAR-T Cells

Published on: March 15, 2021

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...